Pregled bibliografske jedinice broj: 86880
Antiphospholipid antibody syndrome and fetal outcome
Antiphospholipid antibody syndrome and fetal outcome // Acta medica Croatica, 55 (2001), 3; 123-30 (podatak o recenziji nije dostupan, članak, ostalo)
CROSBI ID: 86880 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Antiphospholipid antibody syndrome and fetal outcome
Autori
Đelmiš, Josip ; Radončić, Erden ; Ivanišević, Marina
Izvornik
Acta medica Croatica (1330-0164) 55
(2001), 3;
123-30
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
Antiphospholipid syndrome; pregnancy; fetal loss
Sažetak
The presence of antiphospholipid antibodies, lupus anticoagulant and anticardiolipin antibody in patients with systemic lupus erythematosus has been associated with the clinical features of thrombosis, fetal loss and thrombocytopenia, and the syndrome is designated as antiphospholipid antibody syndrome (APS). APS has been increasingly diagnosed in patients without underlying autoimmune disease and is most frequently seen in obstetric patients suffering spontaneous abortion, preeclampsia and intrauterine growth restriction. The hypothesis underlying most research into the pathophysiology of APS is that autoantibodies are not only the markers of the disease, but also directly contribute to the development of clinical features. This review summarizes recent information on the pathophysiology and potential roles of autoantibodies in the obstetric patients suffering, particularly in the subgroup of repeated spontaneous abortions.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Uključenost u ostale bibliografske baze podataka::
- Excerpta Medica
- Index Medicus